Retraction: Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting (BioMed Research International (2014) 2014 (526391) DOI: 10.1155/2014/526391);Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Shilakari Asthana, Gyati ^a,b   Asthana, Abhay ^a   Kohli, Dharm Veer ^b   Vyas, Suresh Prasad ^b  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CHITOSAN; DEOXYRIBONUCLEASE I; MANNOSE; MANNOSE RECEPTOR; MANNOSYLATED CHITOSAN NANOPARTICLE; MESSENGER RNA; NANOPARTICLE; PHOSPHATE; TJU 2755; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DRUG CARRIER; WATER;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; STATIC ELECTRICITY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENE TRANSFER; METABOLISM; MOLECULAR WEIGHT; SOLUBILITY;

ANIMALS; CELL LINE; CELL SURVIVAL; CHITOSAN; DEOXYRIBONUCLEASE I; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; MACROPHAGES; MANNOSE; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR WEIGHT; NANOPARTICLES; OLIGONUCLEOTIDES, ANTISENSE; PARTICLE SIZE; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA; WATER;

EID: 84904108518     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2021/1878130     Document Type: Erratum

References (137)

1. Tamm I., Dörken B., Hartmann G., Antisense therapy in oncology: new hope for an old idea? The Lancet 2001 358 9280 489 497 10.1016/S0140-6736(01) 05629-X 2-s2.0-0035845318 (Pubitemid 32769863)
2. Crooke S. T., Lebleu B., Antisense Research and Applications 1993 Boca Raton, Fla, USA CRC Press
3. Stein C. A., Cheng Y. C., Antisense oligonucleotides as therapeutic agents-is the bullet really magical? Science 1993 261 5124 1004 1012 10.1126/science.8351515 2-s2.0-0027376439 (Pubitemid 23300859)
4. Akhtar S., Delivery Strategies for Antisense Oligonucleotide Therapeutics 1995 Boca Raton, Fla, USA CRC Press
5. Crooke S. T., Molecular mechanisms of action of antisense drugs. Biochimica et Biophysica Acta-Gene Structure and Expression 1999 1489 1 31 43 10.1016/S0167-4781(99)00148-7 2-s2.0-0032700656
6. Stull R. A., Szoka F. C. Jr., Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects. Pharmaceutical Research 1995 12 4 465 483 10.1023/A:1016281324761 2-s2.0-0028943759
7. Blake K. R., Murakami A., Miller P. S., Inhibition of rabbit globin mRNA translation by sequence-specific oligodeoxyribonucleotides. Biochemistry 1985 24 22 6132 6138 10.1021/bi00343a015 2-s2.0-0022410868 (Pubitemid 16197365)
8. Blake K. R., Murakami A., Spitz S. A., Glave S. A., Reddy M. P., Ts'o P. O. P., Miller P. S., Hybridization arrest of globin synthesis in rabbit reticulocyte lysates and cells by oligodeoxyribonucleoside methylphosphonates. Biochemistry 1985 24 22 6139 6145 10.1021/bi00343a016 2-s2.0-0022360675 (Pubitemid 16197366)
9. Gleave M. E., Monia B. P., Antisense therapy for cancer. Nature Reviews Cancer 2005 5 6 468 479 10.1038/nrc1631 2-s2.0-20344371233 (Pubitemid 40791489)
10. Lewis K. J., Irwin W. J., Akhtar S., Biodegradable poly(l-lactic acid) matrices for the sustained delivery of antisense oligonucleotides. Journal of Controlled Release 1995 37 1-2 173 183 10.1016/0168-3659(95)00100-M 2-s2.0-0028811665
11. Akhtar S., Juliano R. L., Cellular uptake and intracellular fate of antisense oligonucleotides. Trends in Cell Biology 1992 2 5 139 144 10.1016/0962-8924(92)90100-2 2-s2.0-0026550810
12. Shi F., Hoekstra D., Effective intracellular delivery of oligonucleotides in order to make sense of antisense. Journal of Controlled Release 2004 97 2 189 209 10.1016/j.jconrel.2004.03.016 2-s2.0-2942585676 (Pubitemid 38759477)
13. Liu C. M., Liu D. P., Liang C. C., Oligonucleotide-mediated gene repair at DNA level: the potential applications for gene therapy. Journal of Molecular Medicine 2002 80 10 620 628 10.1007/s00109-002-0366-y 2-s2.0-0036460772 (Pubitemid 35471726)
14. Akhtar S., Antisense technology: selection and delivery of optimally acting antisense oligonucleotides. Journal of Drug Targeting 1998 5 4 225 234 10.3109/10611869808995877 2-s2.0-0031694735 (Pubitemid 28404264)
15. Juliano R. L., Alahari S., Yoo H., Kole R., Cho M., Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharmaceutical Research 1999 16 4 494 502 10.1023/A: 1011958726518 2-s2.0-0032960982 (Pubitemid 29191292)
16. Wagner E., Cotten M., Zatloukal K., Gregoriadis G. M., McCormack B., Receptor-mediated gene delivery with synthetic virus-like particles. Targeting of Drugs 5: Strategies for Oligonucleotide and Gene Delivery in Therapy 1995 London, UK Plenum Press 67 77
17. Harada A., Togawa H., Kataoka K., Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-Lysine) block copolymers. European Journal of Pharmaceutical Sciences 2001 13 1 35 42 10.1016/S0928-0987(00)00205-0 2-s2.0-0035080570 (Pubitemid 32259538)
18. Couvreur P., Malvy C., Pharmaceutical Aspects of Oligonuceotides 2000 1 London, UK Taylor and Francis
19. Zon G., Oligonucleotide analogues as potential chemotherapeutic-agents. Pharmaceutical Research 1988 5 9 539 549 10.1023/A:1015985728434 2-s2.0-0023811885
20. Kashihara N., Maeshima Y., Makino H., Antisense oligonucleotides. Experimental Nephrology 1998 6 1 84 88 10.1159/000020509 2-s2.0-0031881609 (Pubitemid 28096342)
21. Akhtar S., Basu S., Wickstrom E., Juliano R. L., Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). Nucleic Acids Research 1991 19 20 5551 5559 10.1093/nar/19.20.5551 2-s2.0-0026009971 (Pubitemid 21912954)
22. Wickstrom E., Akhtar S., Nuclease resistant nucleic acid therapeutics. Delivery Strategies for Antisense Oligonucleotide Therapeutics 1995 Boca Raton, Fla, USA CRC Press 85 104
23. Stein C. A., Phosphorothioate antisense oligodeoxynucleotides: questions of specificity. Trends in Biotechnology 1996 14 5 147 149 10.1016/0167-7799(96) 20006-X 2-s2.0-0029943679 (Pubitemid 26162076)
24. Glover D. J., Lipps H. J., Jans D. A., Towards safe, non-viral therapeutic gene expression in humans. Nature Reviews Genetics 2005 6 4 299 310 10.1038/nrg1577 2-s2.0-15944400651 (Pubitemid 40469049)
25. Lasic D. D., Templeton N. S., Liposomes in gene therapy. Advanced Drug Delivery Reviews 1996 20 2-3 221 266 10.1016/0169-409X(96)00002-6 2-s2.0-0030602786 (Pubitemid 26284164)
26. Rolland A. P., From genes to gene medicines: Recent advances in nonviral gene delivery. Critical Reviews in Therapeutic Drug Carrier Systems 1998 15 2 143 198 10.1615/CritRevTherDrugCarrierSyst.v15.i2.20 2-s2.0-0031970246 (Pubitemid 28208750)
27. Nishikawa M., Huang L., Nonviral vectors in the new millennium: delivery barriers in gene transfer. Human Gene Therapy 2001 12 8 861 870 10.1089/104303401750195836 2-s2.0-0034913116 (Pubitemid 32681851)
28. Zobel H. P., Kreuter J., Werner D., Noe C. R., Kümel G., Zimmer A., Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides. Antisense and Nucleic Acid Drug Development 1997 7 5 483 493 10.1089/oli.1.1997.7.483 2-s2.0-0030779241 (Pubitemid 27491371)
29. Zimmer A., Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Methods 1999 18 3 286 295 10.1006/meth.1999.0786 2-s2.0-0032881090 (Pubitemid 29443614)
30. Fattal E., Vauthier C., Aynie I., Nakada Y., Lambert G., Malvy C., Couvreur P., Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. Journal of Controlled Release 1998 53 1-3 137 143 10.1016/S0168-3659(97)00246-0 2-s2.0-0032580442 (Pubitemid 28218697)
31. Ferreiro M. G., Tillman L., Hardee G., Bodmeier R., Characterization of complexes of an antisense oligonucleotide with protamine and poly-L-lysine salts. Journal of Controlled Release 2001 73 2-3 381 390 10.1016/S0168-3659(01) 00296-6 2-s2.0-0035850241 (Pubitemid 32539264)
32. Junghans M., Kreuter J., Zimmer A., Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles. Biochimica et Biophysica Acta 2001 1544 1-2 177 188 10.1016/S0167-4838(00)00219- 3 2-s2.0-0035847118 (Pubitemid 32121856)
33. Zobel H. P., Junghans M., Maienschein V., Werner D., Gilbert M., Zimmermann H., Noe C., Kreuter J., Zimmer A., Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 2000 49 3 203 210 10.1016/S0939-6411(00)00080-1 2-s2.0-0034595215 (Pubitemid 30229867)
34. Berton M., Allémann E., Stein C. A., Gurny R., Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex. European Journal of Pharmaceutical Sciences 1999 9 2 163 170 10.1016/S0928-0987(99)00049-4 2-s2.0-0343415618 (Pubitemid 30012073)
35. Chavany C., Le Doan T., Couvreur P., Puisieux F., Helene C., Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Pharmaceutical Research 1992 9 4 441 449 10.1023/A: 1015871809313 2-s2.0-0026536219
36. Chavany C., Saison-Behmoaras T., le Doan T., Puisieux F., Couvreur P., Helene C., Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake. Pharmaceutical Research 1994 11 9 1370 1378 10.1023/A:1018923301967 2-s2.0-0027935614 (Pubitemid 24287423)
37. Akhtar S., Lewis K. J., Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres. International Journal of Pharmaceutics 1997 151 1 57 67 10.1016/S0378-5173(97)04887-4 2-s2.0-0030919006 (Pubitemid 27212304)
38. Crooke S. T., Delivery of oligonucleotides and polynucleotides. Journal of Drug Targeting 1995 3 3 185 190 10.3109/10611869509015944 2-s2.0-0028864530
39. DeLong R., Stephenson K., Loftus T., Fisher M., Alahari S., Nolting A., Juliano R. L., Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery. Journal of Pharmaceutical Sciences 1997 86 6 762 764 10.1021/js960409f 2-s2.0-0030926147 (Pubitemid 27248831)
40. Hughes J. A., Aronsohn A. I., Avrutskaya A. V., Juliano R. L., Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides. Pharmaceutical Research 1996 13 3 404 410 10.1023/A:1016044609972 2-s2.0-0029923715 (Pubitemid 26112266)
41. Gewirtz A. M., Sokol D. L., Ratajczak M. Z., Nucleic acid therapeutics: state of the art and future prospects. Blood 1998 92 3 712 736 2-s2.0-0032147234 (Pubitemid 28355453)
42. Junghans M., Kreuter J., Zimmer A., Antisense delivery using protamine-oligonucleotide particles. Nucleic Acids Research 2000 28 10 E45 E47 10.1093/nar/28.10.e45 2-s2.0-0034656564
43. Berton M., Turelli P., Trono D., Stein C., Allémann E., Gurny R., Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles. Pharmaceutical Research 2001 18 8 1096 1101 10.1023/A:1010962507273 2-s2.0-0034807801 (Pubitemid 32900393)
44. Arnedo A., Espuelas S., Irache J. M., Albumin nanoparticles as carriers for a phosphodiester oligonucleotide. International Journal of Pharmaceutics 2002 244 1-2 59 72 10.1016/S0378-5173(02)00300-9 2-s2.0-0037026277 (Pubitemid 35245446)
45. 50 nanoparticles by complexation with structured oligopeptides. Drug Delivery 1996 3 3 187 195 2-s2.0-0029847348 (Pubitemid 26343100)
46. Fritz H., Maier M., Bayer E., Cationic polystyrene nanoparticles: preparation and characterization of a model drug carrier system for antisense oligonucleotides. Journal of Colloid and Interface Science 1997 195 2 272 288 10.1006/jcis.1997.5172 2-s2.0-0031573187 (Pubitemid 28030109)
47. Aynié I., Vauthier C., Chacun H., Fattal E., Couvreur P., Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. Antisense and Nucleic Acid Drug Development 1999 9 3 301 312 10.1089/oli.1.1999.9.301 2-s2.0-0032776762 (Pubitemid 29361064)
48. Schwab G., Chavany C., Duroux I., Goubin G., Lebeau J., Hélène C., Saison-Behmoaras T., Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proceedings of the National Academy of Sciences of the United States of America 1994 91 22 10460 10464 10.1073/pnas.91.22.10460 2-s2.0-0028037219 (Pubitemid 24329017)
49. Lambert G., Fattal E., Brehier A., Feger J., Couvreur P., Effect of polyisobutylcyanoacrylate nanoparticles and Lipofectin loaded with oligonucleotides on cell viability and PKC α neosynthesis in HepG2 cells. Biochimie 1998 80 12 969 976 10.1016/S0300-9084(99)80002-9 2-s2.0-0032293435
50. Arnedo A., Irache J. M., Merodio M., Millán M. S. E., Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide. Journal of Controlled Release 2004 94 1 217 227 10.1016/j.jconrel.2003.10.009 2-s2.0-0347996094 (Pubitemid 37542391)
51. Janes K. A., Calvo P., Alonso M. J., Polysaccharide colloidal particles as delivery systems for macromolecules. Advanced Drug Delivery Reviews 2001 47 1 83 97 10.1016/S0169-409X(00)00123-X 2-s2.0-0035937593 (Pubitemid 32209234)
52. Köping-Höggård M., Tubulekas I., Guan H., Edwards K., Nilsson M., Vårum K. M., Artursson P., Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Therapy 2001 8 14 1108 1121 10.1038/sj.gt.3301492 2-s2.0-0034786764 (Pubitemid 32962708)
53. Howard K. A., Rahbek U. L., Liu X., Damgaard C. K., Glud S. Z., Andersen M. Ø., Hovgaard M. B., Schmitz A., Nyengaard J. R., Besenbacher F., Kjems J., RNA interference in Vitro and in Vivo using a novel chitosan/siRNA nanoparticle system. Molecular Therapy 2006 14 4 476 484 10.1016/j.ymthe.2006. 04.010 2-s2.0-33748054817 (Pubitemid 44296092)
54. Gao S., Chen J., Dong L., Ding Z., Yang Y., Zhang J., Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector. European Journal of Pharmaceutics and Biopharmaceutics 2005 60 3 327 334 10.1016/j.ejpb.2005.02.011 2-s2.0-21544437607 (Pubitemid 40922830)
55. Illum L., Chitosan and its use as a pharmaceutical excipient. Pharmaceutical Research 1998 15 9 1326 1331 10.1023/A:1011929016601 2-s2.0-0031783879 (Pubitemid 28427917)
56. MacLaughlin F. C., Mumper R. J., Wang J., Tagliaferri J. M., Gill I., Hinchcliffe M., Rolland A. P., Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. Journal of Controlled Release 1998 56 1-3 259 272 10.1016/S0168-3659(98)00097-2 2-s2.0-0032484162 (Pubitemid 28511146)
57. Lee M., Chun S., Choi W., Kim J., Choi S., Kim A., Oungbho K., Park J., Ahn W. S., Kim C., The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 2005 26 14 2147 2156 10.1016/j.biomaterials.2004.07.008 2-s2.0-20844431544 (Pubitemid 39575358)
58. Shu X. Z., Zhu K. J., The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. European Journal of Pharmaceutics and Biopharmaceutics 2002 54 2 235 243 10.1016/S0939-6411(02)00052-8 2-s2.0-1842843556 (Pubitemid 34919399)
59. Richardson S. C. W., Kolbe H. V. J., Duncan R., Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. International Journal of Pharmaceutics 1999 178 2 231 243 10.1016/S0378-5173(98)00378-0 2-s2.0-0032990267 (Pubitemid 29078577)
60. Erbacher P., Zou S., Bettinger T., Steffan A. M., Remy J. S., Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharmaceutical Research 1998 15 9 1332 1339 10.1023/A:1011981000671 2-s2.0-0031722107 (Pubitemid 28427918)
61. Park I.-K., Jiang H.-L., Cook S.-E., Cho M.-H., Kim S.-I., Jeong H.-J., Akaike T., Cho C.-S., Galactosylated chitosan (GC)- graft -poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier: in vitro transfection. Archives of Pharmacal Research 2004 27 12 1284 1289 10.1007/BF02975895 2-s2.0-13744260137
62. Kim T. H., Jin H., Kim H. W., Cho M., Cho C. S., Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Molecular Cancer Therapeutics 2006 5 7 1723 1732 10.1158/1535-7163.MCT-05-0540 2-s2.0-33748318169 (Pubitemid 44323240)
63. Thanou M., Florea B. I., Geldof M., Junginger H. E., Borchard G., Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials 2002 23 1 153 159 10.1016/S0142-9612(01)00090-4 2-s2.0-0036027454 (Pubitemid 33041349)
64. Li F., Liu W. G., Yao K. D., Preparation of oxidized glucose-crosslinked N-alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour. Biomaterials 2002 23 2 343 347 10.1016/S0142-9612(01)00111-9 2-s2.0-0036131709 (Pubitemid 33051023)
65. Kim Y. H., Gihm S. H., Park C. R., Lee K. Y., Kim T. W., Kwon I. C., Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjugate Chemistry 2001 12 6 932 938 10.1021/bc015510c 2-s2.0-0035213983 (Pubitemid 33136863)
66. Sato A., Kawakami S., Yamada M., Yamashita F., Hashida M., Enhanced gene transfection in macrophages using mannosylated cationic liposome- polyethylenimine-plasmid DNA complexes. Journal of Drug Targeting 2001 9 3 201 207 10.3109/10611860108997928 2-s2.0-0034882339 (Pubitemid 32776367)
67. Lee M., Nah J.-W., Kwon Y., Koh J. J., Ko K. S., Kim S. W., Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharmaceutical Research 2001 18 4 427 431 10.1023/A:1011037807261 2-s2.0-0034955331 (Pubitemid 32592572)
68. Gao S., Chen J., Xu X., Ding Z., Yang Y., Hua Z., Zhang J., Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. International Journal of Pharmaceutics 2003 255 1-2 57 68 10.1016/S0378-5173(03)00082-6 2-s2.0-0037436976 (Pubitemid 36369591)
69. Cui Z., Mumper R. J., Chitosan-based nanoparticles for topical genetic immunization. Journal of Controlled Release 2001 75 3 409 419 10.1016/S0168-3659(01)00407-2 2-s2.0-0035839201 (Pubitemid 32727270)
70. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A. N., Davis S. S., Chitosan as a novel nasal delivery system for vaccines. Advanced Drug Delivery Reviews 2001 51 1-3 81 96 10.1016/S0169-409X(01)00171-5 2-s2.0-0035940314 (Pubitemid 32763074)
71. Wu G. Y., Wu C. H., Receptor-mediated gene delivery and expression in vivo. The Journal of Biological Chemistry 1988 263 29 14621 14624 2-s2.0-0023811723
72. Kawakami S., Yamashita F., Nishikawa M., Takakura Y., Hashida M., Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochemical and Biophysical Research Communications 1998 252 1 78 83 10.1006/bbrc.1998.9602 2-s2.0-0032501104 (Pubitemid 28534630)
73. Kawakami S., Fumoto S., Nishikawa M., Yamashita F., Hashida M., In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharmaceutical Research 2000 17 3 306 313 10.1023/A:1007501122611 2-s2.0-0034000572 (Pubitemid 30225134)
74. Nishikawa M., Yamauchi M., Morimoto K., Ishida E., Takakura Y., Hashida M., Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Therapy 2000 7 7 548 555 10.1038/sj.gt.3301140 2-s2.0-0034104640 (Pubitemid 30175557)
75. Hashida M., Takemura S., Nishikawa M., Takakura Y., Targeted delivery of plasmid DNA complexed with galactosylated poly(l-lysine). Journal of Controlled Release 1998 53 1-3 301 310 10.1016/S0168-3659(97)00263-0 2-s2.0-0032580535 (Pubitemid 28218713)
76. Mahato R. I., Takemura S., Akamatsu K., Nishikawa M., Takakura Y., Hashida M., Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). Biochemical Pharmacology 1997 53 6 887 895 10.1016/S0006-2952(96)00880-5 2-s2.0-0030907837 (Pubitemid 27145791)
77. Hara T., Aramaki Y., Takada S., Koike K., Tsuchiya S., Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes. Gene 1995 159 2 167 174 10.1016/0378-1119(95)00100-K 2-s2.0-0029059127
78. Hara T., Aramaki Y., Takada S., Koike K., Tsuchiya S., Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes. Gene Therapy 1995 2 10 784 789 2-s2.0-0029616558 (Pubitemid 126662752)
79. Hara T., Kuwasawa H., Aramaki Y., Takada S., Koike K., Ishidate K., Kato H., Tsuchiya S., Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes. Biochimica et Biophysica Acta-Biomembranes 1996 1278 1 51 58 10.1016/0005-2736(95)00205-7 2-s2.0-0030032075 (Pubitemid 26042270)
80. Remy J. S., Kichler A., Mordvinov V., Schuber F., Behr J. P., Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: A stage toward artificial viruses. Proceedings of the National Academy of Sciences of the United States of America 1995 92 5 1744 1748 10.1073/pnas.92.5.1744 2-s2.0-0028939896
81. Ferkol T., Perales J. C., Mularo F., Hanson R. W., Receptor-mediated gene transfer into macrophages. Proceedings of the National Academy of Sciences of the United States of America 1996 93 1 101 105 10.1073/pnas.93.1.101 2-s2.0-0030025910 (Pubitemid 26038110)
82. Erbacher P., Bousser M. T., Raimond J., Monsigny M., Midoux P., Roche A. C., Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Human Gene Therapy 1996 7 6 721 729 10.1089/hum.1996.7.6-721 2-s2.0-0030003605 (Pubitemid 26125842)
83. Kawakami S., Sato A., Nishikawa M., Yamashita F., Hashida M., Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Therapy 2000 7 4 292 299 10.1038/sj.gt.3301089 2-s2.0-0033995526 (Pubitemid 30119732)
84. Kawakami S., Sato A., Yamada M., Yamashita F., Hashida M., The effect of lipid composition on receptor-mediated in vivo gene transfection using mannosylated cationic liposomes in mice. STP Pharma Sciences 2001 11 1 117 120 2-s2.0-0035125644 (Pubitemid 32154867)
85. Nishikawa M., Takemura S., Yamashita F., Takakura Y., Meijer D. K. F., Hashida M., Swart P. J., Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly (L-lysine) in mice. Journal of Drug Targeting 2000 8 1 29 38 10.3109/10611860009009207 2-s2.0-0034027294 (Pubitemid 30189691)
86. Choi Y. H., Liu F., Park J. S., Kim S. W., Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier. Bioconjugate Chemistry 1998 9 6 708 718 10.1021/bc980017v 2-s2.0-0001121655 (Pubitemid 28542238)
87. Wagner E., Zenke M., Cotten M., Beug H., Birnstiel M. L., Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proceedings of the National Academy of Sciences of the United States of America 1990 87 9 3410 3414 10.1073/pnas.87.9.3410 2-s2.0-0025340966 (Pubitemid 20173645)
88. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., Buchberger M., Wagner E., Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Therapy 1997 4 5 409 418 10.1038/sj.gt.3300418 2-s2.0-0030927586 (Pubitemid 27226583)
89. Chen J., Gamou S., Takayanagi A., Shimizu N., A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Letters 1994 338 2 167 169 10.1016/0014-5793(94)80357-9 2-s2.0-0027954666 (Pubitemid 24064958)
90. Varga C. M., Wickham T. J., Lauffenburger D. A., Receptor-mediated targeting of gene delivery vectors: insights from molecular mechanisms for improved vehicle design. Biotechnology and Bioengineering 2000 70 6 593 605
91. Takakura Y., Mahato R. I., Nishikawa M., Hashida M., Control of pharmacokinetic profiles of drug-macromolecule conjugates. Advanced Drug Delivery Reviews 1996 19 3 377 399 10.1016/0169-409X(96)00010-5 2-s2.0-0030580955 (Pubitemid 26227527)
92. Stahl P., Schlesinger P. H., Sigardson E., Rodman J. S., Lee Y. C., Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling. Cell 1980 19 1 207 215 10.1016/0092-8674(80)90402-X 2-s2.0-0018868190 (Pubitemid 10154225)
93. Kuiper J., Brouwer A., Knook D. L., van Berkel T. J. C., Arias I. M., Boyer J. L., Fausto N., Jakoby W. B., Schachter D. A., Shafritz D. A., Kupffer and sinusoidal endothelial cells. The Liver: Biology and Pathobiology 1994 3rd New York, NY, USA Raven Press 791 818
94. Weis W. I., Taylor M. E., Drickamer K., The C-type lectin superfamily in the immune system. Immunological Reviews 1998 163 19 34 10.1111/j.1600-065X. 1998.tb01185.x 2-s2.0-0031820273 (Pubitemid 28327859)
95. Hashimoto M., Morimoto M., Saimoto H., Shigemasa Y., Yanagie H., Eriguchi M., Sato T., Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages. Biotechnology Letters 2006 28 11 815 821 10.1007/s10529-006-9006-x 2-s2.0-33745246316 (Pubitemid 43926904)
96. Katas H., Alpar H. O., Development and characterisation of chitosan nanoparticles for siRNA delivery. Journal of Controlled Release 2006 115 2 216 225 10.1016/j.jconrel.2006.07.021 2-s2.0-33749844509 (Pubitemid 44559708)
97. Monsigny M., Petit C., Roche A. C., Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod. Analytical Biochemistry 1988 175 2 525 530 10.1016/0003-2697(88)90578-7 2-s2.0-0024210793 (Pubitemid 19020409)
98. Jiang L., Qian F., He X., Wang F., Ren D., He Y., Li K., Sun S., Yin C., Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice. Journal of Gene Medicine 2007 9 4 253 264 10.1002/jgm.1017 2-s2.0-34248573630 (Pubitemid 46746316)
99. Huang M., Fong C. W., Khor E., Lim L. Y., Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. Journal of Controlled Release 2005 106 3 391 406 10.1016/j.jconrel.2005.05.004 2-s2.0-23944439174 (Pubitemid 41187448)
100. Park Y. K., Park Y. H., Shin B. A., Choi E. S., Park Y. R., Akaike T., Cho C. S., Galactosylated chitosan- graft -dextran as hepatocyte-targeting DNA carrier. Journal of Controlled Release 2000 69 1 97 108 10.1016/S0168-3659(00) 00298-4 2-s2.0-0034601856
101. Sundaram S., Lee L. K., Roth C. M., Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity. Nucleic Acids Research 2007 35 13 4396 4408 10.1093/nar/gkm450 2-s2.0-34547830367 (Pubitemid 47244591)
102. Gray G. D., Wickstrom E., Rapid measurement of modified oligonucleotide levels in plasma samples with a fluorophore specific for single-stranded DNA. Antisense and Nucleic Acid Drug Development 1997 7 3 133 140 10.1089/oli.1.1997.7.133 2-s2.0-0030843081 (Pubitemid 27323071)
103. Kim T. H., Park I. K., Nah J. W., Choi Y. J., Cho C. S., Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials 2004 25 17 3783 3792 10.1016/j.biomaterials.2003.10.063 2-s2.0-1542268858 (Pubitemid 38327067)
104. Sgouras D., Duncan R., Methods for the evaluation of biocompatibility of soluble synthetic polymers which have potential for biomedical use: 1-use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for evaluation of in vitro cytotoxicity. Journal of Materials Science: Materials in Medicine 1990 1 2 61 68 10.1007/BF00839070 2-s2.0-34249959310
105. Pan X., Chen L., Liu S., Yang X., Gao J., Lee R. J., Antitumor activity of G3139 lipid nanoparticles (LNPs). Molecular Pharmaceutics 2009 6 1 211 220 10.1021/mp800146j 2-s2.0-62649158435
106. Yamauchi M., Kusano H., Saito E., Iwata T., Nakakura M., Kato Y., Uochi T., Akinaga S., Aoki N., Improved formulations of antisense oligodeoxynucleotides using wrapped liposomes. Journal of Controlled Release 2006 114 2 268 275 10.1016/j.jconrel.2006.05.025 2-s2.0-33747891997 (Pubitemid 44291849)
107. Kim S., Kim E., Hou J., Kim J., Choi H., Shim C., Oh Y., Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides. Biomaterials 2009 30 5 959 967 10.1016/j.biomaterials. 2008.10.031 2-s2.0-57549118342
108. Salvati A., Ciani L., Ristori S., Martini G., Masi A., Arcangeli A., Physico-chemical characterization and transfection efficacy of cationic liposomes containing the pEGFP plasmid. Biophysical Chemistry 2006 121 1 21 29 10.1016/j.bpc.2005.12.009 2-s2.0-33745963773 (Pubitemid 44389493)
109. Dong L., Xia S., Luo Y., Diao H., Zhang J., Chen J., Targeting delivery oligonucleotide into macrophages by cationic polysaccharide from Bletilla striata successfully inhibited the expression of TNF- α Journal of Controlled Release 2009 134 3 214 220 10.1016/j.jconrel.2008.11.013 2-s2.0-61349144250
110. Nah J., Jang M., Spectroscopic characterization and preparation of low molecular, water-soluble chitosan with free-amine group by novel method. Journal of Polymer Science A: Polymer Chemistry 2002 40 21 3796 3803 10.1002/pola.10463 2-s2.0-0036842077 (Pubitemid 35275097)
111. Kim D. G., Choi C., Jeong Y. I., Jang M. K., Nah J. W., Rang S. K., Bang M. S., All-trans retinoic acid-associated low molecular weight water-soluble chitosan nanoparticles based on ion complex. Macromolecular Research 2006 14 1 66 72 10.1007/BF03219070 2-s2.0-33644824293 (Pubitemid 43357129)
112. De Lima M. C. P., Simões S., Pires P., Faneca H., Düzgüneş N., Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Advanced Drug Delivery Reviews 2001 47 2-3 277 294 10.1016/S0169-409X(01)00110-7 2-s2.0-0035946624 (Pubitemid 32324118)
113. Thomas M., Klibanov A. M., Non-viral gene therapy: polycation-mediated DNA delivery. Applied Microbiology and Biotechnology 2003 62 1 27 34 10.1007/s00253-003-1321-8 2-s2.0-0038574350 (Pubitemid 36836536)
114. Seymour L. W., Passive tumor targeting of soluble macromolecules and drug conjugates. Critical Reviews in Therapeutic Drug Carrier Systems 1992 9 2 135 187 2-s2.0-0026694788
115. Prabha S., Zhou W., Panyam J., Labhasetwar V., Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. International Journal of Pharmaceutics 2002 244 1-2 105 115 10.1016/S0378-5173(02)00315-0 2-s2.0-0037026269 (Pubitemid 35245451)
116. Kunath K., von Harpe A., Fischer D., Kissel T., Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency. Journal of Controlled Release 2003 88 1 159 172 10.1016/S0168-3659(02)00458-3 2-s2.0-0037436017 (Pubitemid 36173961)
117. Petersen H., Fechner P. M., Martin A. L., Kunath K., Stolnik S., Roberts C. J., Fischer D., Davies M. C., Kissel T., Polyethylenimine- graft -poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjugate Chemistry 2002 13 4 845 854 10.1021/bc025529v 2-s2.0-0036077937 (Pubitemid 34801128)
118. Mahato R. I., Takakura Y., Hashida M., Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations. Critical Reviews in Therapeutic Drug Carrier Systems 1997 14 2 133 172 2-s2.0-0030890713 (Pubitemid 27169245)
119. Mahato R. I., Kawabata K., Nomura T., Takakura Y., Hashida M., Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. Journal of Pharmaceutical Sciences 1995 84 11 1267 1271 10.1002/jps.2600841102 2-s2.0-0028863071
120. Kim J., Kim B., Maruyama A., Akaike T., Kim S. W., A new non-viral DNA delivery vector: the terplex system. Journal of Controlled Release 1998 53 1-3 175 182 10.1016/S0168-3659(97)00251-4 2-s2.0-0032580531 (Pubitemid 28218700)
121. Barry M. E., Pinto-González D., Orson F. M., McKenzie G. J., Petry G. R., Barry M. A., Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Human Gene Therapy 1999 10 15 2461 2480 10.1089/10430349950016816 2-s2.0-2442761730 (Pubitemid 29489721)
122. Park I. K., Kim T. H., Park Y. H., Shin B. A., Choi E. S., Chowdhury E. H., Akaike T., Cho C. S., Galactosylated chitosan- graft -poly(ethylene glycol) as hepatocyte-targeting DNA carrier. Journal of Controlled Release 2001 76 3 349 362 10.1016/S0168-3659(01)00448-5 2-s2.0-0035914230 (Pubitemid 32913442)
123. Moghimi S. M., Symonds P., Murray J. C., Hunter A. C., Debska G., Szewczyk A., A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Molecular Therapy 2005 11 6 990 995 10.1016/j.ymthe.2005.02.010 2-s2.0-19444372923 (Pubitemid 40724119)
124. Zhao Q.-Q., Chen J.-L., Han M., Liang W.-Q., Tabata Y., Gao J.-Q., Combination of poly(ethylenimine) and chitosan induces high gene transfection efficiency and low cytotoxicity. Journal of Bioscience and Bioengineering 2008 105 1 65 68 10.1263/jbb.105.65 2-s2.0-39449125413 (Pubitemid 351273667)
125. Carreño-Gómez B., Duncan R., Evaluation Of the biological properties of soluble chitosan and chitosan microspheres. International Journal of Pharmaceutics 1997 148 2 231 240 10.1016/S0378-5173(96)04847-8 2-s2.0-0004472732 (Pubitemid 27160980)
126. Kunath K., von Harpe A., Fischer D., Petersen H., Bickel U., Voigt K., Kissel T., Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. Journal of Controlled Release 2003 89 1 113 125 10.1016/S0168-3659(03)00076-2 2-s2.0-0037437033 (Pubitemid 36412116)
127. Jiang H., Kim Y., Arote R., Jere D., Quan J., Yu J., Choi Y., Nah J., Cho M., Cho C., Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting. International Journal of Pharmaceutics 2009 375 1-2 133 139 10.1016/j.ijpharm.2009.03.033 2-s2.0-67349091776
128. Park I. Y., Kim I. Y., Yoo M. K., Choi Y. J., Cho M., Cho C. S., Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. International Journal of Pharmaceutics 2008 359 1-2 280 287 10.1016/j.ijpharm.2008.04.010 2-s2.0-44749086164
129. Corsi K., Chellat F., Yahia L., Fernandes J. C., Mesenchymal stem cells,
130. Zhou X., Liu B., Yu X., Zha X., Zhang X., Chen Y., Wang X., Jin Y., Wu Y., Chen Y., Shan Y., Chen Y., Liu J., Kong W., Shen J., Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine. Journal of Controlled Release 2007 121 3 200 207 10.1016/j.jconrel.2007.05.018 2-s2.0-34547653774 (Pubitemid 47214651)
131. Jiang H., Kang M. L., Quan J., Kang S. G., Akaike T., Yoo H. S., Cho C., The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials 2008 29 12 1931 1939 10.1016/j.biomaterials.2007.12.025 2-s2.0-39749157155
132. Diebold S. S., Kursa M., Wagner E., Cotten M., Zenke M., Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. The Journal of Biological Chemistry 1999 274 27 19087 19094 10.1074/jbc.274.27.19087 2-s2.0-0033516472 (Pubitemid 29314105)
133. Mi R. P., Ki O. H., In K. H., Myung H. C., Jae W. N., Yun J. C., Chong S. C., Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. Journal of Controlled Release 2005 105 3 367 380 10.1016/j.jconrel.2005.04.008 2-s2.0-21744445582 (Pubitemid 40942000)
134. Lu Y., Kawakami S., Yamashita F., Hashida M., Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes. Biomaterials 2007 28 21 3255 3262 10.1016/j.biomaterials.2007.03.028 2-s2.0-34247471316 (Pubitemid 46654220)
135. Hattori Y., Suzuki S., Kawakami S., Yamashita F., Hashida M., The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. Journal of Controlled Release 2005 108 2-3 484 495 10.1016/j.jconrel.2005.08.012 2-s2.0-27744566572 (Pubitemid 41608679)
136. Rojanasakul Y., Weissman D. N., Shi X., Castranova V., Ma J. K. H., Liang W., Antisense inhibition of silica-induced tumor necrosis factor in alveolar macrophages. The Journal of Biological Chemistry 1997 272 7 3910 3914 10.1074/jbc.272.7.3910 2-s2.0-0031041890 (Pubitemid 27078447)
137. Taylor M. F., Paulauskis J. D., Weller D. D., Kobzik L., Comparison of efficacy of antisense oligomers directed toward TNF- α in helper T and macrophage cell lines. Cytokine 1997 9 9 672 681 10.1006/cyto.1997.0212 2-s2.0-0031239634 (Pubitemid 27399834)